3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Suspended
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
1
Pain
1
Interventions
pembrolizumab
3
Drug Therapy
3
Vincristine
2
S 1 (combination)
2
Nivolumab
2
Gemcitabine
2
Cyclophosphamide
2
CA-4948
2
Bevacizumab
2
zimberelimab
1
venetoclax
1
titanium silicide
1
tisagenlecleucel
1
sotigalimab
1
propranolol CR
1
prednylidene
1
pimonidazole
1
palbociclib
1
mirdametinib
1
imisopasem manganese
1
gusacitinib
1
fludarabine
1
deltacortene
1
brincidofovir
1
axicabtagene ciloleucel
1
Testosterone Propionate
1
Testosterone
1
Temozolomide
1
TPI-287
1
Sorafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Suspended
×
Extracorporeal Shockwave Therapy
×
Clear all
NCT00637364
2009-01-13
HIFU Pancreas
CMED HIFU Development Corporation
Phase 1/2
Suspended
5 enrolled